论文部分内容阅读
联合化疗可诱导55～80％的急性粒细胞白血病完全缓解。为了增加急性粒细胞白血病的缓解率,必须找出治疗失败的原因并采取特殊的对策,作者对缓解诱导治疗10天一疗程,已给药6天后的患者作骨髓活检,证明既可识别能获得缓解的大部分患者,又可识别因疗效不佳而不能获得缓解的患者,从而可选择性地对这些患者加强缓解诱导治疗。作者对53例各型急性粒细胞白血病患者,以阿糖胞苷(100mg/m~2/天)连续注射10天。在治疗的第
Combined chemotherapy can induce complete remission of 55-80% of acute myeloid leukemia. In order to increase the remission rate of acute myelogenous leukemia, it is necessary to find out the causes of treatment failure and take special countermeasures. The authors performed a bone marrow biopsy for patients who had been given a course of 10 days for induction therapy and had been administered for 6 days. Most of the remission patients can also identify patients who are unable to obtain remission due to poor efficacy, so that selective remission induction therapy can be selectively applied to these patients. The authors consecutively injected cytarabine (100 mg/m~2/day) for 10 consecutive days in 53 patients with various forms of acute myelogenous leukemia. In the treatment of the